Is a complete RPID research report available?

No complete published report is available for Rapid Micro Biosystems, Inc. (RPID) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Rapid Micro Biosystems, Inc. (RPID)

NASDAQ: RPID · USD

$1.99

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first RPID analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	98.3M
Revenue (ttm)	34.4M
Net income (ttm)	-50.1M
EPS (ttm)	-$1.11
Shares out	49.4M
Volume	193,818
Beta	1.47
Price target	$6.67	+235.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 34.4M
Net income (ttm): -50.1M
EPS (ttm): -$1.11
Market cap: 98.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RPID indicators

Market & fundamental data

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001380106
Company name	Rapid Micro Biosystems, Inc.
Country	United States
Country code	US
Cusip	75340L104
Employees	171
Employees Change	8%
Employees Change Percent	4.91
Enterprise value	$98.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	40.31
Industry PE Fwd	18.65
IPO Date	2021-07-15
Isin	US75340L1044
Last refreshed	2026-07-25
Market cap	$98.3M
Market cap category	Micro-Cap
Price	$1.99
Price currency	USD
Rev Per Employee	201,076.02x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	3826
Symbol	RPID
Website	https://www.rapidmicrobio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-50.98%
EV Sales Forward	3.14x
EV/Sales	2.86x
FCF yield	-38.62%
P/B ratio	4.46x
P/S ratio	2.86x
PS Forward	3.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-144.2%
EBITDA Margin	-135.16%
Gross margin	2.95%
Gross Profit	$1M
Gross Profit Growth	-44.22%
Gross Profit Growth Q	-8.17%
Net Income	$-50.1M
Net Income Growth Years	0%
Pretax Margin	-145.69%
Profit Margin	-145.81%
Profit Per Employee	$-293,187
ROA	-41.94
Roa5y	-23.7
ROCE	-114.7
ROE	-116.7
Roe5y	-52.58
ROIC	-53.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-50.64%
Cagr3y	26.63%
Cagr5y	-37.66%
EPS Growth Years	5
Revenue Growth	15.99x
Revenue Growth Q	11.06x
Revenue Growth Quarters	13x
Revenue Growth Years	3x
Revenue Growth3 Y	24.06x
Revenue Growth5 Y	13.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.47
Assets	$62.4M
Cash	$23.7M
Current Assets	$49.2M
Current Liabilities	$19.1M
Debt	$23.7M
Debt Equity	$1.16
Equity	$20.4M
Interest Coverage	-28.88
Liabilities	$42M
Long Term Assets	$13.1M
Long Term Liabilities	$22.8M
Net Cash	$6,000
Net Cash By Market Cap	$0.01
Net Cash Growth	-99.98%
Net Debt Equity	$-0
Tangible Book Value	$20.4M
Tangible Book Value Per Share	$0.45
WACC	11.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.57
Inventory Turnover	1.75
Net Working Capital	$7.7M
Quick ratio	1.58
Working Capital	$30.1M
Working Capital Turnover	$0.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.92%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-50.62%
200-day SMA	2.97
3Y total return	103.06%
50-day SMA	1.92
50-day SMA vs 200-day SMA	50under200
5Y total return	-90.58%
All Time High	27.04
All Time High Change	-92.64%
All Time High Date	2021-08-03
All Time Low	0.58
All Time Low Change	243.1%
All Time Low Date	2024-07-03
ATR	0.13
Beta	1.47
Beta1y	1.89
Beta2y	1.15
Ch YTD	-31.38
High	2.02
High52	4.94
High52 Date	2026-01-29
High52ch	-59.72%
Low	1.95
Low52	1.66
Low52 Date	2026-06-16
Low52ch	19.88%
Ma50ch	3.7%
Premarket Change Percent	-0.5
Premarket Price	$1.98
Price vs 200-day SMA	-33.09%
RSI	52.94
RSI Monthly	43.66
RSI Weekly	40.13
Sharpe ratio	-0.43x
Sortino ratio	-0.55
Total Return	-2.92%
Tr YTD	-31.38
Tr1m	17.75%
Tr1w	-3.86%
Tr3m	-11.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	3
Analyst Price Target Top	$7.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.25
Earnings Revenue Estimate	7,860,000x
Earnings Revenue Estimate Growth	8.23x
Operating Income	$-49.6M
Operating margin	-144.2
Price target	$6.67
Price Target Change	$235
Price Target Change Top	$277

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32,226,529%
Float Percent	65.21%
Net Borrowing	19,968,000
Shares Insiders	3.06%
Shares Institutions	21.15%
Shares Out	49,419,647
Shares Qo Q	1.83%
Shares Yo Y	2.92%
Short Float	2.29%
Short Ratio	4.48
Short Shares	1.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-42.2M
Average Volume	248,732.45x
Bv Per Share	0.45
CAPEX	$-925,000
Ch1m	17.75
Ch1w	-3.86
Ch1y	-50.62
Ch3m	-11.56
Ch3y	103.1
Ch5y	-90.58
Ch6m	-51.7
Change	0%
Change From Open	-0.5
Close	1.99
Days Gap	0.5
Depreciation Amortization	2,711,000
Dollar Volume	385,697.8
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-49.6M
EBITDA	$-46.5M
EPS	$-1.11
F Score	2
FCF	$-38M
FCF EV Yield	-38.62x
FCF Per Share	$-0.77
Financing CF	19,639,000
Fiscal Year End	December
Founded	2,006
Income Tax	$41,000
Investing CF	12,244,000
Ipr	-90.05
Iprfo	-91.16
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	2.79
Ma150ch	-28.55%
Ma20	1.91
Ma20ch	4.03%
Net CF	-5,172,000
Next Earnings Date	2026-08-07
Open	2
Optionable	No
Position In Range	57.14
Post Close	1.99
Postmarket Change Percent	3.02
Postmarket Price	$2.05
Ppne	12,608,000
Pre Close	1.99
Price Date	2026-07-24
Ptbv Ratio	4.82
Relative Volume	0.78x
Revenue	34,384,000x
SBC By Revenue	12.26x
Share Based Comp	4,214,000
Tax By Revenue	0.12x
Tr6m	-51.7%
Us State	Massachusetts
Volume	193,818
Z Score	-11.46

Rapid Micro Biosystems, Inc. (RPID)

Coverage state: Market snapshot only — no published research

Generate the first RPID analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · RPID

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RPID indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RPID

Frequently asked questions